Incyte Corporation (INCY) stock analysis

In our weekly check, Incyte Corporation is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 2.

About Incyte Corporation

Incyte Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as INCY.

What our checks show for INCY

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-09

Similar companies

UTHR · INSM · ALNY · ROIV · BNTX · GMAB

Questions

What grade does Incyte Corporation (INCY) have?

In our weekly check, Incyte Corporation is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of INCY stock?

This week's biggest flags for Incyte Corporation: Margins falling, Deep past fall, Gross margin falling. In total 6 of 24 checks show a warning or a red flag.

What does Incyte Corporation do?

Incyte Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as INCY.

When does Incyte Corporation report earnings next?

The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis